These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9225956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Metallothionein induction prevents toxic side effects of cisplatin and adriamycin used in combination.
    Satoh M, Naganuma A, Imura N.
    Cancer Chemother Pharmacol; 1988; 21(2):176-8. PubMed ID: 3349566
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.
    Liu Y, Liu J, Habeebu SM, Waalkes MP, Klaassen CD.
    Toxicol Sci; 2000 Sep; 57(1):167-76. PubMed ID: 10966523
    [Abstract] [Full Text] [Related]

  • 25. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity.
    Liu J, Liu Y, Habeebu SS, Klaassen CD.
    Toxicol Appl Pharmacol; 1998 Mar; 149(1):24-31. PubMed ID: 9512723
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pulmonary toxicity caused by acute exposure to mercury vapor is enhanced in metallothionein-null mice.
    Yoshida M, Satoh M, Shimada A, Yasutake A, Sumi Y, Tohyama C.
    Life Sci; 1999 Mar; 64(20):1861-7. PubMed ID: 10350360
    [Abstract] [Full Text] [Related]

  • 33. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M, Vannozzi M, Viale M, Pellecchia C, Civalleri D, Gogioso L.
    Anticancer Res; 1995 Mar; 15(6B):2541-7. PubMed ID: 8669820
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation.
    Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, Cai L.
    Circulation; 2006 Jan 31; 113(4):544-54. PubMed ID: 16432057
    [Abstract] [Full Text] [Related]

  • 38. [The effect of zinc glycyrrhizate on toxicity and anticancer activity of cisplatin in mice].
    Xu ZL, Guo JH, Song ST, Li MJ, Wu DZ.
    Yao Xue Xue Bao; 1993 Jan 31; 28(8):567-71. PubMed ID: 8285063
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Role of metallothionein in cancer chemotherapy].
    Naganuma A, Imura N.
    Gan To Kagaku Ryoho; 1994 Feb 31; 21(3):301-6. PubMed ID: 8109985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.